Three young researchers are poised to revolutionize the future of childhood cancer treatment in Australia, backed by a substantial funding boost. Dr. Claire Sun, Dr. Zoe Day, and Dr. Stacie Wang have been awarded the Children's Cancer CoLab Future Leaders Fellowships, collectively receiving over $1.3 million to develop targeted therapies for the most devastating childhood cancers. This funding addresses a critical disparity in cancer research, where over 100 targeted drugs have been approved for adults, yet only 19 have been approved for children.
Dr. Sun, a bioinformatician at the Hudson Institute of Medical Research, is leveraging artificial intelligence and epigenomics to decipher the unique biology of childhood brain tumours. Her research aims to create new precision drug targets and a clinical decision-support tool to match children with the most effective treatments. Dr. Day, based at WEHI, is pioneering CAR T-cell combination immunotherapies for DIPG, a childhood brain cancer with a grim prognosis. Her goal is to replace the gruelling radiotherapy with a more manageable regimen of monthly infusions. Dr. Wang, a paediatric oncologist at The Royal Children's Hospital and a researcher at WEHI, is focusing on the safety and efficacy of CAR T-cell therapy, including the impact of chemotherapy. She is also establishing Victoria's first CAR T clinical trial for children with brain cancer, targeting a protein called EphA3.
These researchers are not just making scientific breakthroughs; they are also addressing a critical talent gap in Australia's paediatric oncology workforce. The CoLab Future Leaders Impact Program, supported by the Victorian Government and Children's Cancer Foundation, aims to build specialist capability and retain world-leading expertise in Australia. By fostering multidisciplinary collaboration and building Australia's international standing in childhood cancer research and care, this program is ensuring that the country's most promising young researchers have the resources they need to make a lasting impact.
In my opinion, this funding is a crucial step towards a brighter future for children with cancer. The work of these researchers not only holds the promise of more effective treatments but also challenges the status quo in cancer research. It is a testament to the power of innovation and collaboration, and it highlights the importance of investing in the next generation of scientific talent. As these researchers continue to push the boundaries of what is possible, they are not just changing the future for Aussie kids with cancer; they are changing the landscape of pediatric oncology worldwide.
